I agree that this site is using cookies. You can find further informations here.
X
Barraco, N.
125  results:
Search for persons X
?
1

Current clinically validated applications of liquid biopsy:

, In: Liquid Biopsy,
Capoluongo, E. ; Rolfo, C. ; Galvano, A.... - p. 63-81 , 2023
Link: https://doi.org/10.1016/..
 
?
2

List of contributors:

, In: Liquid Biopsy,
Arbitrio, M. ; Badalamenti, G. ; Barraco, N.... - p. xi-xiv , 2023
Link: https://doi.org/10.1016/..
 
?
3

Future perspectives:

, In: Liquid Biopsy,
Incorvaia, L. ; La Mantia, M. ; Cutaia, S.... - p. 221-225 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Molecular tumor board:

, In: Liquid Biopsy,
La Mantia, M. ; Busuito, G. ; Spinnato, V.... - p. 211-219 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Prospective On-Treatment Dynamics of Circulating Extracellu..:

Gristina, V. ; Malapelle, U. ; Barraco, N....
The Journal of Liquid Biopsy.  1 (2023)  - p. 100083 , 2023
Link: https://doi.org/10.1016/..
 
?
6

EP08.03-007 Spontaneous Regression in Metastatic Non-small ..:

La Mantia, M. ; De Monte, L. ; Tancredi, G....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S492-S493 , 2022
Link: https://doi.org/10.1016/..
 
?
7

EP16.01-013 The Diagnostic Accuracy of Tumor Mutational Bur..:

La Mantia, M. ; Gristina, V. ; Galvano, A....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S560 , 2022
Link: https://doi.org/10.1016/..
 
?
8

Impact of deleterious variants in other genes beyond BRCA1/..:

Bono, M. ; Fanale, D. ; Incorvaia, L....
ESMO Open.  6 (2021)  4 - p. 100235 , 2021
Link: https://doi.org/10.1016/..
 
?
9

The prognostic impact of tumor mutational burden (TMB) in t..:

Galvano, A. ; Gristina, V. ; Malapelle, U....
ESMO Open.  6 (2021)  3 - p. 100124 , 2021
Link: https://doi.org/10.1016/..
 
?
10

The prognostic impact of tumor mutational burden (TMB) in t..:

Galvano, A ; Gristina, V ; Malapelle, U...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111593/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
11

Impact of deleterious variants in other genes beyond BRCA1/..:

Bono M ; Fanale D ; Incorvaia L...
info:eu-repo/semantics/altIdentifier/pmid/34371384.  , 2021
Link: http://hdl.handle.net/10..
 
?
12

Impact of deleterious variants in other genes beyond BRCA1/..:

Bono, M ; Fanale, D ; Incorvaia, L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358413/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
13

Is there any room for PD-1 inhibitors in combination with p..:

Gristina V ; Galvano A ; Castellana L...
info:eu-repo/semantics/altIdentifier/wos/WOS:000697406500001.  , 2021
Link: http://hdl.handle.net/10..
 
?
14

Not all KIT 557/558 codons mutations have the same prognost..:

Incorvaia L ; Badalamenti G ; Fanale D...
info:eu-repo/semantics/altIdentifier/pmid/34616493.  , 2021
Link: http://hdl.handle.net/10..
 
?
15

The prognostic impact of tumor mutational burden (TMB) in t..:

Galvano A ; Gristina V ; Malapelle U...
info:eu-repo/semantics/altIdentifier/pmid/33940346.  , 2021
Link: http://hdl.handle.net/10..
 
1-15